Dynocardia, Inc.
Overview
Developed out of MIT and Tufts Medical from a NIH grant, Dynocardia was formed to commercialize the ViTrack™ technology which is the first of its kind, cuff-less, wearable technology for continuous, non-invasive blood pressure (cNIBP) monitoring, addressing the unmet clinical need for out-patient diagnosis and management of the billion+ worldwide with hypertension and in-hospital patient monitoring to prevent complications and reduce costs.